Skip to content

The effect of galacto-oligosaccharides in constipated adults

The effect of galacto-oligosaccharides in constipated adults - TRANSIT study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49026
Enrollment
132
Registered
2020-06-15
Start date
2020-08-03
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

constipation hard stool

Interventions

The subjects, divided in 3 study groups (44 persons each) will consume either one of the interventions: GOS: Biotis* GOS Omni powder, containing 15.1 gr powder with 11 gr active GOS (once per day)

Sponsors

FrieslandCampina Research
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Males and females Age * 18 years BMI *18,5 and * 28,0 kg m2. Healthy as assessed by the NIZO health questionnaire Self-reported constipation according to the Rome IV criteria with the following criteria (for the last 3 months): Fewer than three (3) bowel movements per week. And one or more of the criteria below: * Straining during at least 25% of all defecations * Lumpy or hard stools (BSFS 1-2) in at least 25% of defecations, * Sensation of incomplete evacuation for at least 25% of defecations, * Sensation of anorectal obstruction/blockage for at least 25% of defecations, * Manual manoeuvres to facilitate at least 25% of defecation (e.g., digital evacuation, support of the pelvic floor) *Willingness to abstain from laxatives during the study

Exclusion criteria

Exclusion criteria: - Major abdominal surgery interfering with GI function - Major co-morbidities,such as diagnosed inflammatory bowel disease, diagnosed celiac disease, diagnosed diverticulitis, a history of gastrointestinal tumors and other unforeseen co-morbidities, that may have an impact on the study results (as decided by the medical investigator) - Use of medication that may affect the results of the investigational product, such as physician prescribed laxatives, and medication that influences the motility of the GI tract -Use of antibiotics 90 days before the start of the study -Use of strict diets (Vegan diet, gluten free diet, or crash-diet with use of meal replacers) -Self-reported lactose-intolerance - Self reported cow's milk allergy - Diagnosed diabetes -Pregnant and lactating women -Expected change in lifestyle within 14 days before and during the trial period (i.e. diet, physical activity, smoking, alcohol consumption and medication use) -History of side effect with the use of prebiotic supplements -Use of alcoholic beverages for men > 28 units/week and >4/day; for women: >21 units/week and >3/day

Design outcomes

Primary

MeasureTime frame
Self-reported stool frequency, assessed weekly, in weekly in online questionnaires

Secondary

MeasureTime frame
Self-reported stool consistency, assessed weekly in online questionnaires with the Bristol 7-point stool scale.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)